Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine
Forgoing postoperative radioactive iodine in low-risk differentiated thyroid cancer is supported by phase 3 data.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | Hematology | Iodine | Thyroid | Thyroid Cancer